The role of blood pressure lowering before and after stroke

被引：18

作者：

Donnan, GA

Davis, SM

Thrift, A

机构：

[1] Univ Melbourne, Austin & Repatriat Med Ctr, Natl Stroke Res Inst, Heidelberg West, Vic 3081, Australia

[2] Royal Melbourne Hosp, Dept Neurol, Parkville, Vic 3050, Australia

来源：

CURRENT OPINION IN NEUROLOGY | 2003年 / 16卷 / 01期

关键词：

blood pressure; stroke;

D O I：

10.1097/00019052-200302000-00011

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Blood pressure lowering for primary prevention of stroke should be undertaken using a variety of therapeutic agents. For secondary stroke prevention perindopril based therapy should be used based on current evidence. Uncertainty still exists as to whether blood pressure lowering in the acute stroke setting is safe or improves outcomes.

引用

页码：81 / 86

页数：6

共 54 条

[21] European stroke prevention study .2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke [J].

Diener, HC ;

Cunha, L ;

Forbes, C ;

Sivenius, J ;

Smets, P ;

Lowenthal, A .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 143 (1-2) :1-13

[22]

DONNAN GA, 1994, HYPERTENS RES, V17, pS51

[23] Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischemic stroke [J].

Dyker, AG ;

Grosset, DG ;

Lees, K .

STROKE, 1997, 28 (03) :580-583

[24] A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) [J].

Gent, M ;

Beaumont, D ;

Blanchard, J ;

Bousser, MG ;

Coffman, J ;

Easton, JD ;

Hampton, JR ;

Harker, LA ;

Janzon, L ;

Kusmierek, JJE ;

Panak, E ;

Roberts, RS ;

Shannon, JS ;

Sicurella, J ;

Tognoni, G ;

Topol, EJ ;

Verstraete, M ;

Warlow, C .

LANCET, 1996, 348 (9038) :1329-1339

[25] Effect of antihypertensive treatment in patients having already suffered from stroke - Gathering the evidence [J].

Gueyffier, F ;

Boissel, JP ;

Boutitie, F ;

Pocock, S ;

Coope, J ;

Cutler, J ;

Ekbom, T ;

Fagard, R ;

Friedman, L ;

Kerlikowske, K ;

Perry, M ;

Prineas, R ;

Schron, E .

STROKE, 1997, 28 (12) :2557-2562

[26] Study on COgnition and Prognosis in the Elderly (SCOPE):: Baseline characteristics [J].

Hansson, L ;

Lithell, H ;

Skoog, I ;

Baro, F ;

Bánki, CM ;

Breteler, M ;

Castaigne, A ;

Correia, M ;

Degaute, JP ;

Elmfeldt, D ;

Engedal, K ;

Farsang, C ;

Ferro, J ;

Hachinski, V ;

Hofman, A ;

James, OFW ;

Krisin, E ;

Leeman, M ;

De Leeuw, PW ;

Leys, D ;

Lobo, A ;

Nordby, G ;

Olofsson, B ;

Opolski, G ;

Prince, M ;

Reischies, FM ;

Rosenfeld, JB ;

Ruilope, L ;

Salerno, J ;

Tilvis, R ;

Trenkwalder, P ;

Zanchetti, A .

BLOOD PRESSURE, 2000, 9 (2-3) :146-151

[27]

Hansson L, 1999, BLOOD PRESSURE, V8, P177

[28] Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats [J].

Inada, Y ;

Wada, T ;

Ojima, M ;

Sanada, T ;

Shibouta, Y ;

Kanagawa, R ;

Ishimura, Y ;

Fujisawa, Y ;

Nishikawa, K .

CLINICAL AND EXPERIMENTAL HYPERTENSION, 1997, 19 (07) :1079-1099

[29] THE J-CURVE PHENOMENON IN STROKE RECURRENCE [J].

IRIE, K ;

YAMAGUCHI, T ;

MINEMATSU, K ;

OMAE, T .

STROKE, 1993, 24 (12) :1844-1849

[30]

KOUDSTAAL PJ, 1993, LANCET, V342, P1255

← 1 2 3 4 5 6 →